Launch conference explores balancing safety, quality and cost-effectiveness and containment and cross-contamination issues for highly potent APIs

LONDON, UNITED KINGDOM, January 17, 2017 /EINPresswire.com/ -- In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs).

With this latest development, SMi has launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place this May in London, UK.

Working in close proximity with APIs high in potency and cytotoxicity results in numerous regulations and requirements and further presenting pharmaceutical companies with several difficulties and challenges such as handling, containment, cost and security issues. Thus the two day agenda will endeavour to explore new innovative containment risk assessment tools and containment strategies, providing guidance for the evaluation and management of cross-contamination.
The HPAPI conference will unite outsourcing experts and industrial hygiene leaders along with process and analytical chemists who will focus on relevant areas of discussion.

The expert speaker line up will also address the latest control strategies and solutions, whilst pharmaceutical companies present their approaches to scale-up processes as well as discuss manufacturing facility designs and requirements. Featured specialist include:
• Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungrary
• Richard Denk, Head of Sales Containment, SKAN AG
• Shay Carmi, OPEX QC Workstream Leader Teva Tech Site, Teva TAPI
• Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb
• Bob Sussman, Managing Director, Safe Bridge Consultants
• Jack Brown, Senior Principle Scientist, Boehringer

Visit www.highlypotentapi.com/ein for more information or to view the complete two day agenda.
There is currently a £400 early bird discount for all bookings made before 31st January.

Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2017
22nd – 23rd May 2017
London, UK
www.highlypotentapi.com/ein
Follow the conversation on Twitter and LinkedIn at #SMiHPAPI17

Kyra Williams
SMi Group Ltd
+44 (0)20 7827 6012
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.